In association with
Date: Thursday 2nd July 2020 – 14:00 BST
Artificial Intelligence (AI) is now an integral part of the pharmaceutical industry, where is it is adding significantly to the drug discovery process. In the latest of ELRIG’s ongoing series of webinars, we explores its impact, and see how it is applied with two case studies of using AI for drug discovery.
Confirmed Speakers
Ola Engkvist (AstraZeneca)
‘How AI can be used to accelerate the development of novel medicines’
Peju Oshisanya (Benevolent AI)
‘AI implementation in drug discovery and considerations for diversity’